PeptideLabs Logo
PeptideLabs
Documentación de Calidad
Back to all 64 profiles
Community/research information onlyNo aprobado por FDA/EMA

Community protocol · Semax

Semax: community information and evidence, clearly separated.

A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.

Also known as: XA · ACTH(4-7) analogue

Sources checked: 27 August 2026

Aviso importante de seguridad y responsabilidad

Esta página documenta y evalúa información de comunidades. No es consejo médico ni terapéutico, asesoramiento individual ni invitación al uso.

No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.

Quick context

Semax

Se investiga para señales de protección y plasticidad neuronal; carece de aprobación FDA/EMA.

No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.

Amounts, timing and cycles

Community/research information only

No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.

Amount status

Different amounts circulate online; no regulator-confirmed safe or effective dose exists.

Profile evidence level: preclinical.

Timing

Community claims about time of day, fasting windows or training intervals are not validated clinical standards.

No individual recommendation.

Cycle/duration

Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.

No individual recommendation.

External community reference available

The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.

Open community source

Reconstitución y conversión U-100

Calculadora de reconstitución

For clearly identified single lyophilised substances, the calculator only shows the arithmetic between vial amount, liquid volume and target amount. It does not check identity, purity, sterility, solubility, stability or solvent suitability. The entered target is not a recommendation.

Calculadora de reconstitución

Calculates concentration, volume and theoretical U-100 units. The preloaded 200 µg is only the reference page's arithmetic example.

Concentration

3,333.33 µg/ml

Calculated volume

0.06 ml

U-100 units

6 U

Calculated portions per vial

50

Calculation aid, not dosage or use advice. Incorrect inputs, a different syringe scale, measurement error, dead space or unknown vial content produce incorrect results.

Mechanism and research questions

Synthetic ACTH-derived peptide

Semax is classified as “Synthetic ACTH-derived peptide”. Se investiga para señales de protección y plasticidad neuronal; carece de aprobación FDA/EMA. This describes the investigated pathway but does not validate a community use, amount, route or combination.

01

Señalización neuroprotectora

Se examina si una sustancia puede proteger las células nerviosas del estrés o el daño, por ejemplo tras la falta de oxígeno en un modelo celular. Se miden la supervivencia celular y los marcadores de señalización en tejido nervioso en condiciones de laboratorio.

02

Señalización neuroendocrina

Esto examina cómo se comunican entre sí el sistema nervioso y las glándulas productoras de hormonas, de forma similar a una línea telefónica bidireccional que conecta el cerebro con órganos distantes. Los investigadores suelen medir los niveles hormonales en sangre junto con marcadores de actividad del sistema nervioso.

03

Señalización ansiolítica

Esto estudia cómo un péptido afecta las respuestas de estrés y ansiedad en modelos animales, de forma similar a observar si un animal permanece más tranquilo en un entorno desconocido. Se miden pruebas de comportamiento y niveles de hormonas del estrés.

What communities discuss

These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.

Foros de nootrópicos

Se discuten los efectos subjetivos sobre la concentración, el estado de ánimo o la percepción del estrés tras tomar neuropéptidos experimentales, a menudo basándose en diarios personales. Estas impresiones autoinformadas están fuertemente influenciadas por la expectativa y no reemplazan a los estudios controlados.

Foros de biohacking y longevidad

Los usuarios comparan combinaciones de péptidos ensambladas por ellos mismos con el objetivo de influir en los procesos de envejecimiento o los niveles de energía, a menudo basándose en análisis de sangre o escalas subjetivas de bienestar. Los autoexperimentos personales y las promesas de marketing no reemplazan a los estudios controlados a largo plazo en humanos.

Discusión de origen y pureza

Se discute qué proveedores se consideran más confiables y cómo difieren los resultados de las pruebas de pureza entre lotes. Estas evaluaciones comunitarias se basan en muestras limitadas y no reemplazan las pruebas de laboratorio independientes de cada lote individual.

Adverse effects and risk boundaries

  • Los efectos centrales pueden incluir fatiga, agitación, cefalea, mareo y cambios de sueño o ánimo. Las interacciones y la seguridad neuropsiquiátrica a largo plazo son inciertas.
  • Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
  • A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Exclusion groups and professional assessment

  • Embarazo, epilepsia, enfermedad psiquiátrica o neurológica grave y medicación sedante o estimulante concomitante requieren revisión médica.
  • Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
  • Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

  • Los estudios pueden seguir cognición, sueño, ánimo, constantes y eventos adversos; las impresiones subjetivas diarias no sustituyen mediciones estandarizadas.
  • Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

Preclínico

Carece de aprobación de la FDA/EMA; la evidencia proviene principalmente de modelos experimentales.

Published evidence

Los datos disponibles provienen principalmente de modelos animales o celulares; faltan datos sólidos de eficacia y seguridad en humanos.

Semax se deriva de la ACTH y se vincula más con la plasticidad neuronal, mientras que Selank deriva de la tuftsina y se asocia más con la señalización de ansiedad y estrés.

Storage and stability

  • The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
  • Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
  • Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.

Troubleshooting and error sources

  • U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
  • Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
  • Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
  • Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

No aprobado por FDA/EMA

No existe medicamento aprobado por FDA o EMA; eficacia y seguridad no están establecidas.

WADA 2026

The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.

WADA — 2026 Prohibited List

Combinations / stacks

  • Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
  • Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
  • Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.